Resources

In 2008, the South African National Department of Social Development initiated the Thogomelo project with the support of the United States Agency for International Development. PATH and Mott MacDonald Development South Africa (MM) (previously known as Health and Development Africa) managed the project, whose fundamental goal is to strengthen South Africa’s capacity to care for its community caregivers (CCGs) and to protect vulnerable children. The Thogomelo project aims to ensure the emotional well-being of CCGs, who form the backbone of community-based support to vulnerable children and others in need of care.

The series covers the three menstrual health themes—normalizing taboos, menstrual hygiene products (access, affordability, and appropriateness), and disposal systems and access to infrastructure in the Indian context.

The Gavi Full Country Evaluations (FCE) are mixed-method, prospective evaluations in Mozambique, Uganda, and Zambia and funded by Gavi, the Vaccine Alliance. The second phase of the FCE (FCE2), was implemented from 2017 to 2018, aimed to identify drivers of vaccine coverage and equity with an emphasis on Gavi’s contribution. Evaluation results are intended to support the ongoing learning and improvement of Gavi and national immunization programs. The implementation of FCE2 was guided by a number of principles to ensure the usefulness, relevance, and quality of FCE2’s findings, and of the sustainability and transferability of the platform beyond FCE2. FCE2 was implemented by a consortium of evaluators in collaboration with the national immunization programs in each country: Health Alliance International and Universidade Eduardo Mondlane (Mozambique); Infectious Diseases Research Collaboration (Uganda); University of Zambia (Zambia); and PATH (United States).

This brief outlines PATH’s priorities at the 70th World Health Assembly, including access to essential medicines; immunization; epidemic preparedness; maternal, adolescent, and child health; and more.

Training panel instructions for the SD Bioline Lympatic Filariasis IgG4 rapid diagnostic test